Form 4: Boston Scientific SVP, GC and Corp. Secretary Vance R. Brown Reports Stock Sale
SEC Form 4 Filing
Vance R. Brown, SVP, GC and Corp. Secretary of Boston Scientific, reports the sale of 4,826 shares of common stock at a price of $106.42 on May 21, 2025, under a pre-established Rule 10b5-1 trading plan.
Summary
- On May 21, 2025, Vance R. Brown, the SVP, GC and Corp. Secretary of Boston Scientific Corp [BSX], sold 4,826 shares of common stock.
- The sale was executed at a price of $106.42 per share.
- Following the transaction, Brown directly owns 31,367 shares of Boston Scientific common stock.
- The transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on November 21, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine insider transaction under a pre-established trading plan.
Industry Context
This is a routine disclosure of an insider stock sale. Such sales are common and may not necessarily indicate a negative outlook on the company, especially when executed under a pre-established trading plan.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, but the pre-established trading plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 2024-11-21 | Date of adoption of the Rule 10b5-1 trading plan |
| 2025-05-21 | Date of stock sale transaction |
| 2025-05-22 | Date of signature on the Form 4 filing |
Keywords
Form 4, insider trading, stock sale, Rule 10b5-1, Vance R. Brown, Boston Scientific, BSX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.